1. Home
  2. AMRX vs HNI Comparison

AMRX vs HNI Comparison

Compare AMRX & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • HNI
  • Stock Information
  • Founded
  • AMRX 2002
  • HNI 1944
  • Country
  • AMRX United States
  • HNI United States
  • Employees
  • AMRX N/A
  • HNI N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • HNI Office Equipment/Supplies/Services
  • Sector
  • AMRX Health Care
  • HNI Consumer Discretionary
  • Exchange
  • AMRX Nasdaq
  • HNI Nasdaq
  • Market Cap
  • AMRX 2.5B
  • HNI 2.6B
  • IPO Year
  • AMRX N/A
  • HNI N/A
  • Fundamental
  • Price
  • AMRX $8.01
  • HNI $53.85
  • Analyst Decision
  • AMRX Strong Buy
  • HNI Strong Buy
  • Analyst Count
  • AMRX 5
  • HNI 1
  • Target Price
  • AMRX $10.00
  • HNI $63.00
  • AVG Volume (30 Days)
  • AMRX 1.1M
  • HNI 269.8K
  • Earning Date
  • AMRX 11-08-2024
  • HNI 10-29-2024
  • Dividend Yield
  • AMRX N/A
  • HNI 2.46%
  • EPS Growth
  • AMRX N/A
  • HNI 159.58
  • EPS
  • AMRX N/A
  • HNI 2.56
  • Revenue
  • AMRX $2,680,420,000.00
  • HNI $2,563,700,000.00
  • Revenue This Year
  • AMRX $17.86
  • HNI $5.42
  • Revenue Next Year
  • AMRX $3.90
  • HNI $2.73
  • P/E Ratio
  • AMRX N/A
  • HNI $20.81
  • Revenue Growth
  • AMRX 12.32
  • HNI 10.36
  • 52 Week Low
  • AMRX $5.01
  • HNI $39.95
  • 52 Week High
  • AMRX $9.48
  • HNI $58.42
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 42.36
  • HNI 41.62
  • Support Level
  • AMRX $7.68
  • HNI $52.94
  • Resistance Level
  • AMRX $8.18
  • HNI $54.84
  • Average True Range (ATR)
  • AMRX 0.29
  • HNI 1.08
  • MACD
  • AMRX -0.04
  • HNI -0.44
  • Stochastic Oscillator
  • AMRX 25.41
  • HNI 13.53

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

Share on Social Networks: